Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
Abstract
A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises at least one functionalized hydroxyalkyl phosphine donor group and one or more sulfur or nitrogen donor and a metal combined with the ligand. 21 figs.
- Inventors:
- Issue Date:
- Research Org.:
- Univ. of Missouri, Columbia, MO (United States)
- Sponsoring Org.:
- USDOE, Washington, DC (United States)
- OSTI Identifier:
- 321274
- Patent Number(s):
- 5855867
- Application Number:
- PAN: 8-818,080; TRN: 99:003339
- Assignee:
- Univ. of Missouri, Columbia, MO (United States)
- DOE Contract Number:
- FG02-89ER60875
- Resource Type:
- Patent
- Resource Relation:
- Other Information: PBD: 5 Jan 1999
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 55 BIOLOGY AND MEDICINE, BASIC STUDIES; 40 CHEMISTRY; RADIOPHARMACEUTICALS; CHEMICAL PREPARATION; DIAGNOSTIC USES; THERAPEUTIC USES; LIGANDS
Citation Formats
Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, and Ketring, A R. Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same. United States: N. p., 1999.
Web.
Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, & Ketring, A R. Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same. United States.
Katti, K V, Karra, S R, Berning, D E, Smith, C J, Volkert, W A, and Ketring, A R. Tue .
"Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same". United States.
@article{osti_321274,
title = {Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same},
author = {Katti, K V and Karra, S R and Berning, D E and Smith, C J and Volkert, W A and Ketring, A R},
abstractNote = {A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises at least one functionalized hydroxyalkyl phosphine donor group and one or more sulfur or nitrogen donor and a metal combined with the ligand. 21 figs.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1999},
month = {1}
}